Morgan Stanley Initiates Coverage on Mindray Medical (MR) with an Overweight
Morgan Stanley initiates coverage on Mindray Medical (NYSE: MR) with an Overweight. Price target $50.
Mindray Medical International Limited is developer, manufacturer and marketer of medical devices in China.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
